How to buy PetIQ stock (PETQ)

PetIQ is a drug manufacturers - specialty & generic business based in the US. PetIQ shares (PETQ) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $30.98 – the same closing value as a week prior. PetIQ employs 1,121 staff and has a trailing 12-month revenue of around $1.1 billion.

Our top picks for where to buy PetIQ stock

Buy PetIQ stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

PetIQ stock price (NASDAQ: PETQ)

Use our graph to track the performance of PETQ stocks over time.

PetIQ shares at a glance

• Key figures

Information last updated 2024-12-15.

Latest market close	$30.98
52-week range	$15.09 - $31.06
50-day moving average more info button	$30.73
200-day moving average more info button	$22.52
Wall St. target price	$30.50
PE ratio more info button	83.7297
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$0.37

Is it a good time to buy PetIQ stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

PetIQ price performance over time

Historical closes compared with the close of $30.98 from 2024-10-24

1 week (2024-12-10)	N/A
1 month (2024-11-17)	N/A
3 months (2024-09-20)	0.78%
6 months (2024-06-21)	42.24%

1 year (2023-12-21)	60.94%
2 years (2022-12-21)	224.06%
3 years (2021-12-21)	36.12%
5 years (2019-12-20)	19.80%

Is PetIQ stock undervalued or overvalued?

Valuing PetIQ stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PetIQ's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

PetIQ's P/E ratio

PetIQ's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 84x. In other words, PetIQ shares trade at around 84x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

PetIQ's PEG ratio

PetIQ's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.5616. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PetIQ's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

PetIQ's EBITDA

PetIQ's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $101.7 million.

The EBITDA is a measure of a PetIQ's overall financial performance and is widely used to measure a its profitability.

PetIQ financials

Revenue TTM	$1.1 billion
Operating margin TTM	8.63%
Gross profit TTM	$209.7 million
Return on assets TTM	4.86%
Return on equity TTM	5.52%
Profit margin	1.16%
Book value	$8.71
Market Capitalization more info button	$926.6 million

TTM: trailing 12 months

PetIQ share dividends

We're not expecting PetIQ to pay a dividend over the next 12 months.

PetIQ share price volatility

Over the last 12 months, PetIQ's shares have ranged in value from as little as $15.09 up to $31.06. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PetIQ's is 1.736. This would suggest that PetIQ's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

PetIQ overview

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names.

Frequently asked questions

What percentage of PetIQ is owned by insiders or institutions?
Currently 6.997% of PetIQ shares are held by insiders and 101.998% by institutions. How many people work for PetIQ?
Latest data suggests 1,121 work at PetIQ. When does the fiscal year end for PetIQ?
PetIQ's fiscal year ends in December. Where is PetIQ based?
PetIQ's address is: 230 East Riverside Drive, Eagle, ID, United States, 83616 What is PetIQ's ISIN number?
PetIQ's international securities identification number is: US71639T1060 What is PetIQ's CUSIP number?
PetIQ's Committee on Uniform Securities Identification Procedures number is: 71639T106